Kynurenine 3-monooxygenase (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kynurenine 3-monooxygenase" in English language version.

refsWebsite

Global rank English rank

34nih.gov

4^th place

25doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3harvard.edu

18^th place

17^th place

1worldcat.org

5^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Amaral, M. (2014). "Crystal Structure of kynurenine 3-monooxygenase – truncated at position 394 plus HIS tag cleaved". doi:10.2210/pdb4j34/pdb. {{cite journal}}: Cite journal requires |journal= (help)
Filippini, Graziella Allegri; Costa, Carlo V. L.; Bertazzo, Antonella; International Meeting on Tryptophan Research (1998). Recent advances in tryptophan research: tryptophan and serotonin pathways. Advances in Experimental Medicine and Biology. Vol. 398. doi:10.1007/978-1-4613-0381-7. ISBN 978-1-4613-8026-9. S2CID 38080353.
Smith, Jason R.; Jamie, Joanne F.; Guillemin, Gilles J. (February 2016). "Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors". Drug Discovery Today. 21 (2): 315–324. doi:10.1016/j.drudis.2015.11.001. ISSN 1359-6446. PMID 26589832.
Horn, U.; Ullrich, V.; Staudinger, H.J (1971). "Purification and characterization of L-kynurenine 3-hydroxylase (EC 1.14.1.2.) from rat liver". Hoppe-Seyler's Z. Physiol. Chem. 352 (6): 837–842. doi:10.1515/bchm2.1971.352.1.837. PMID 5087636.
Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS (2013). "Structural basis of kynurenine 3-monooxygenase inhibition". Nature. 496 (7445): 382–385. Bibcode:2013Natur.496..382A. doi:10.1038/nature12039. PMC 3736096. PMID 23575632.
Hirai KH, et al. (2010). "Dual role of the carboxyl-terminal region of pig liver L-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity". J. Biochem. 148 (6): 639–650. doi:10.1093/jb/mvq099. PMID 20802227.
Mole D, et al. (2016). "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis". Nature Medicine. 22 (2): 202–209. doi:10.1038/nm.4020. PMC 4871268. PMID 26752518.
Breton, J.; et al. (2000). "Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase". Eur. J. Biochem. 267 (4): 1092–1099. doi:10.1046/j.1432-1327.2000.01104.x. PMID 10672018.
Crozier-Reabe, KR; et al. (2008). "Kynurenine 3-monooxygenase from Pseudomonas fluorescens: substrate-like inhibitors both stimulate flavin reduction and stabilize the flavin-peroxo intermediate yet result in the production of hydrogen peroxide". Biochemistry. 47 (47): 12420–12433. doi:10.1021/bi8010434. PMID 18954092.
Entsch B, et al. (1976). "Flavin-oxygen derivatives involved in the hydroxylation of p-hydroxybenzoate hydroxylase". J. Biol. Chem. 251 (9): 2550–2563. doi:10.1016/S0021-9258(17)33523-8. PMID 816794.
Thevandavakkam MA, et al. (2010). "Targeting kynurenine 3-monooxygenase (KMO). Implications for therapy in Huntington's disease". CNS Neurol. Disord. Drug Targets. 9 (6): 791–800. doi:10.2174/187152710793237430. PMID 20942784.
Giorgini F, Huang SY, Sathyasaikumar KV, et al. (2013). "Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A New Tool for Studying Kynurenine Pathway Metabolism in Periphery and Brain". The Journal of Biological Chemistry. 288 (51): 36554–36566. doi:10.1074/jbc.M113.503813. PMC 3868768. PMID 24189070.
Rios, C.; Santamaria, A. (1991). "Quinolinic acid is a potent lipid peroxidant in rat brain homogenates". Neurochem. Res. 16 (10): 1139–1143. doi:10.1007/bf00966592. PMID 1686636. S2CID 28669340.
Stone, T. W.; Perkins, M. N. (1981). "Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS". Eur. J. Pharmacol. 72 (4): 411–412. doi:10.1016/0014-2999(81)90587-2. PMID 6268428.
Schwarcz, R.; Bruno, J. P.; Muchowski, P. J.; Wu, H. Q. (2012). "Kynurenines in the mammalian brain. When physiology meets pathology". Nat. Rev. Neurosci. 13 (7): 465–477. doi:10.1038/nrn3257. PMC 3681811. PMID 22678511.
Hilmas, C.; Pereira, E. F.; Alkondon, M.; Rassoulpour, A.; Schwarcz, R.; Albuquerque, E. X. (2001). "The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:Physiopathological implications". J. Neurosci. 21 (19): 7463–7473. doi:10.1523/JNEUROSCI.21-19-07463.2001. PMC 6762893. PMID 11567036.
Giorgini, F.; Guidetti, P.; Nguyen, Q.; Bennett, S. C.; Muchowski, P. J. (2005). "A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease". Nat. Genet. 37 (5): 526–531. doi:10.1038/ng1542. PMC 1449881. PMID 15806102.
Campesan, S.; Green, E. W.; Breda, C.; Sathyasaikumar, K. V.; Muchowski, P. J.; Schwarcz, R.; Kyriacou, C. P.; Giorgini, F (2011). "The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease". Curr. Biol. 21 (11): 961–966. Bibcode:2011CBio...21..961C. doi:10.1016/j.cub.2011.04.028. PMC 3929356. PMID 21636279.
Müller, N; Myint, AM; Schwarz, MJ (2010). "Inflammatory Biomarkers and Depression". Neurotox. Res. 19 (2): 308–318. doi:10.1007/s12640-010-9210-2. PMID 20658274. S2CID 3225744.
Wonodi I, Colin-Stine O, Sathyasaikumar KV, et al. (2011). "Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes". Arch Gen Psychiatry. 68 (7): 665–674. doi:10.1001/archgenpsychiatry.2011.71. PMC 3855543. PMID 21727251.
Holtze M, Saetre P, Engberg G, et al. (2012). "Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls". J Psychiatry Neurosci. 37 (1): 53–57. doi:10.1503/jpn.100175. PMC 3244499. PMID 21693093.
Campbell, Brian M.; Charych, Erik; Lee, Anna W.; Möller, Thomas (2014). "Kynurenines in CNS disease: regulation byinflammatory cytokines". Frontiers in Neuroscience. 8 (12): 12. doi:10.3389/fnins.2014.00012. PMC 3915289. PMID 24567701.
Hoekstra, PJ; Anderson, GM; Troost, PW (2007). "Plasma kynurenine and related measures in tic disorder patients". Eur Child Adolesc Psychiatry. 16 (Suppl 1): 71–77. doi:10.1007/s00787-007-1009-1. PMID 17665285. S2CID 39150343.
Buness A, Roth A, Herrmann A, Schmitz O, Kamp H, et al. (2014). "Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity". PLOS ONE. 9 (5) e97249. Bibcode:2014PLoSO...997249B. doi:10.1371/journal.pone.0097249. PMC 4023975. PMID 24836604.
Yukiko, Hirata; Takashi, Kawachi; Takashi, Sugimura (2 October 1967). "Fatty liver induced by injection of L-tryptophan". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 144 (2): 233–241. doi:10.1016/0005-2760(67)90153-1. PMID 4168935.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS (2013). "Structural basis of kynurenine 3-monooxygenase inhibition". Nature. 496 (7445): 382–385. Bibcode:2013Natur.496..382A. doi:10.1038/nature12039. PMC 3736096. PMID 23575632.
Campesan, S.; Green, E. W.; Breda, C.; Sathyasaikumar, K. V.; Muchowski, P. J.; Schwarcz, R.; Kyriacou, C. P.; Giorgini, F (2011). "The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease". Curr. Biol. 21 (11): 961–966. Bibcode:2011CBio...21..961C. doi:10.1016/j.cub.2011.04.028. PMC 3929356. PMID 21636279.
Buness A, Roth A, Herrmann A, Schmitz O, Kamp H, et al. (2014). "Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity". PLOS ONE. 9 (5) e97249. Bibcode:2014PLoSO...997249B. doi:10.1371/journal.pone.0097249. PMC 4023975. PMID 24836604.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Smith, Jason R.; Jamie, Joanne F.; Guillemin, Gilles J. (February 2016). "Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors". Drug Discovery Today. 21 (2): 315–324. doi:10.1016/j.drudis.2015.11.001. ISSN 1359-6446. PMID 26589832.
Horn, U.; Ullrich, V.; Staudinger, H.J (1971). "Purification and characterization of L-kynurenine 3-hydroxylase (EC 1.14.1.2.) from rat liver". Hoppe-Seyler's Z. Physiol. Chem. 352 (6): 837–842. doi:10.1515/bchm2.1971.352.1.837. PMID 5087636.
Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS (2013). "Structural basis of kynurenine 3-monooxygenase inhibition". Nature. 496 (7445): 382–385. Bibcode:2013Natur.496..382A. doi:10.1038/nature12039. PMC 3736096. PMID 23575632.
Hirai KH, et al. (2010). "Dual role of the carboxyl-terminal region of pig liver L-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity". J. Biochem. 148 (6): 639–650. doi:10.1093/jb/mvq099. PMID 20802227.
Mole D, et al. (2016). "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis". Nature Medicine. 22 (2): 202–209. doi:10.1038/nm.4020. PMC 4871268. PMID 26752518.
Breton, J.; et al. (2000). "Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase". Eur. J. Biochem. 267 (4): 1092–1099. doi:10.1046/j.1432-1327.2000.01104.x. PMID 10672018.
Crozier-Reabe, KR; et al. (2008). "Kynurenine 3-monooxygenase from Pseudomonas fluorescens: substrate-like inhibitors both stimulate flavin reduction and stabilize the flavin-peroxo intermediate yet result in the production of hydrogen peroxide". Biochemistry. 47 (47): 12420–12433. doi:10.1021/bi8010434. PMID 18954092.
Entsch B, et al. (1976). "Flavin-oxygen derivatives involved in the hydroxylation of p-hydroxybenzoate hydroxylase". J. Biol. Chem. 251 (9): 2550–2563. doi:10.1016/S0021-9258(17)33523-8. PMID 816794.
Thevandavakkam MA, et al. (2010). "Targeting kynurenine 3-monooxygenase (KMO). Implications for therapy in Huntington's disease". CNS Neurol. Disord. Drug Targets. 9 (6): 791–800. doi:10.2174/187152710793237430. PMID 20942784.
Giorgini F, Huang SY, Sathyasaikumar KV, et al. (2013). "Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A New Tool for Studying Kynurenine Pathway Metabolism in Periphery and Brain". The Journal of Biological Chemistry. 288 (51): 36554–36566. doi:10.1074/jbc.M113.503813. PMC 3868768. PMID 24189070.
Rios, C.; Santamaria, A. (1991). "Quinolinic acid is a potent lipid peroxidant in rat brain homogenates". Neurochem. Res. 16 (10): 1139–1143. doi:10.1007/bf00966592. PMID 1686636. S2CID 28669340.
Stone, T. W.; Perkins, M. N. (1981). "Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS". Eur. J. Pharmacol. 72 (4): 411–412. doi:10.1016/0014-2999(81)90587-2. PMID 6268428.
Schwarcz, R.; Bruno, J. P.; Muchowski, P. J.; Wu, H. Q. (2012). "Kynurenines in the mammalian brain. When physiology meets pathology". Nat. Rev. Neurosci. 13 (7): 465–477. doi:10.1038/nrn3257. PMC 3681811. PMID 22678511.
Hilmas, C.; Pereira, E. F.; Alkondon, M.; Rassoulpour, A.; Schwarcz, R.; Albuquerque, E. X. (2001). "The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:Physiopathological implications". J. Neurosci. 21 (19): 7463–7473. doi:10.1523/JNEUROSCI.21-19-07463.2001. PMC 6762893. PMID 11567036.
Giorgini, F.; Guidetti, P.; Nguyen, Q.; Bennett, S. C.; Muchowski, P. J. (2005). "A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease". Nat. Genet. 37 (5): 526–531. doi:10.1038/ng1542. PMC 1449881. PMID 15806102.
Campesan, S.; Green, E. W.; Breda, C.; Sathyasaikumar, K. V.; Muchowski, P. J.; Schwarcz, R.; Kyriacou, C. P.; Giorgini, F (2011). "The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease". Curr. Biol. 21 (11): 961–966. Bibcode:2011CBio...21..961C. doi:10.1016/j.cub.2011.04.028. PMC 3929356. PMID 21636279.
Müller, N; Myint, AM; Schwarz, MJ (2010). "Inflammatory Biomarkers and Depression". Neurotox. Res. 19 (2): 308–318. doi:10.1007/s12640-010-9210-2. PMID 20658274. S2CID 3225744.
Wonodi I, Colin-Stine O, Sathyasaikumar KV, et al. (2011). "Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes". Arch Gen Psychiatry. 68 (7): 665–674. doi:10.1001/archgenpsychiatry.2011.71. PMC 3855543. PMID 21727251.
Holtze M, Saetre P, Engberg G, et al. (2012). "Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls". J Psychiatry Neurosci. 37 (1): 53–57. doi:10.1503/jpn.100175. PMC 3244499. PMID 21693093.
Campbell, Brian M.; Charych, Erik; Lee, Anna W.; Möller, Thomas (2014). "Kynurenines in CNS disease: regulation byinflammatory cytokines". Frontiers in Neuroscience. 8 (12): 12. doi:10.3389/fnins.2014.00012. PMC 3915289. PMID 24567701.
Hoekstra, PJ; Anderson, GM; Troost, PW (2007). "Plasma kynurenine and related measures in tic disorder patients". Eur Child Adolesc Psychiatry. 16 (Suppl 1): 71–77. doi:10.1007/s00787-007-1009-1. PMID 17665285. S2CID 39150343.
Buness A, Roth A, Herrmann A, Schmitz O, Kamp H, et al. (2014). "Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity". PLOS ONE. 9 (5) e97249. Bibcode:2014PLoSO...997249B. doi:10.1371/journal.pone.0097249. PMC 4023975. PMID 24836604.
Yukiko, Hirata; Takashi, Kawachi; Takashi, Sugimura (2 October 1967). "Fatty liver induced by injection of L-tryptophan". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 144 (2): 233–241. doi:10.1016/0005-2760(67)90153-1. PMID 4168935.

ncbi.nlm.nih.gov

Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS (2013). "Structural basis of kynurenine 3-monooxygenase inhibition". Nature. 496 (7445): 382–385. Bibcode:2013Natur.496..382A. doi:10.1038/nature12039. PMC 3736096. PMID 23575632.
Mole D, et al. (2016). "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis". Nature Medicine. 22 (2): 202–209. doi:10.1038/nm.4020. PMC 4871268. PMID 26752518.
Giorgini F, Huang SY, Sathyasaikumar KV, et al. (2013). "Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A New Tool for Studying Kynurenine Pathway Metabolism in Periphery and Brain". The Journal of Biological Chemistry. 288 (51): 36554–36566. doi:10.1074/jbc.M113.503813. PMC 3868768. PMID 24189070.
Schwarcz, R.; Bruno, J. P.; Muchowski, P. J.; Wu, H. Q. (2012). "Kynurenines in the mammalian brain. When physiology meets pathology". Nat. Rev. Neurosci. 13 (7): 465–477. doi:10.1038/nrn3257. PMC 3681811. PMID 22678511.
Hilmas, C.; Pereira, E. F.; Alkondon, M.; Rassoulpour, A.; Schwarcz, R.; Albuquerque, E. X. (2001). "The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:Physiopathological implications". J. Neurosci. 21 (19): 7463–7473. doi:10.1523/JNEUROSCI.21-19-07463.2001. PMC 6762893. PMID 11567036.
Giorgini, F.; Guidetti, P.; Nguyen, Q.; Bennett, S. C.; Muchowski, P. J. (2005). "A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease". Nat. Genet. 37 (5): 526–531. doi:10.1038/ng1542. PMC 1449881. PMID 15806102.
Campesan, S.; Green, E. W.; Breda, C.; Sathyasaikumar, K. V.; Muchowski, P. J.; Schwarcz, R.; Kyriacou, C. P.; Giorgini, F (2011). "The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease". Curr. Biol. 21 (11): 961–966. Bibcode:2011CBio...21..961C. doi:10.1016/j.cub.2011.04.028. PMC 3929356. PMID 21636279.
Wonodi I, Colin-Stine O, Sathyasaikumar KV, et al. (2011). "Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes". Arch Gen Psychiatry. 68 (7): 665–674. doi:10.1001/archgenpsychiatry.2011.71. PMC 3855543. PMID 21727251.
Holtze M, Saetre P, Engberg G, et al. (2012). "Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls". J Psychiatry Neurosci. 37 (1): 53–57. doi:10.1503/jpn.100175. PMC 3244499. PMID 21693093.
Campbell, Brian M.; Charych, Erik; Lee, Anna W.; Möller, Thomas (2014). "Kynurenines in CNS disease: regulation byinflammatory cytokines". Frontiers in Neuroscience. 8 (12): 12. doi:10.3389/fnins.2014.00012. PMC 3915289. PMID 24567701.
Buness A, Roth A, Herrmann A, Schmitz O, Kamp H, et al. (2014). "Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity". PLOS ONE. 9 (5) e97249. Bibcode:2014PLoSO...997249B. doi:10.1371/journal.pone.0097249. PMC 4023975. PMID 24836604.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Filippini, Graziella Allegri; Costa, Carlo V. L.; Bertazzo, Antonella; International Meeting on Tryptophan Research (1998). Recent advances in tryptophan research: tryptophan and serotonin pathways. Advances in Experimental Medicine and Biology. Vol. 398. doi:10.1007/978-1-4613-0381-7. ISBN 978-1-4613-8026-9. S2CID 38080353.
Rios, C.; Santamaria, A. (1991). "Quinolinic acid is a potent lipid peroxidant in rat brain homogenates". Neurochem. Res. 16 (10): 1139–1143. doi:10.1007/bf00966592. PMID 1686636. S2CID 28669340.
Müller, N; Myint, AM; Schwarz, MJ (2010). "Inflammatory Biomarkers and Depression". Neurotox. Res. 19 (2): 308–318. doi:10.1007/s12640-010-9210-2. PMID 20658274. S2CID 3225744.
Hoekstra, PJ; Anderson, GM; Troost, PW (2007). "Plasma kynurenine and related measures in tic disorder patients". Eur Child Adolesc Psychiatry. 16 (Suppl 1): 71–77. doi:10.1007/s00787-007-1009-1. PMID 17665285. S2CID 39150343.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Smith, Jason R.; Jamie, Joanne F.; Guillemin, Gilles J. (February 2016). "Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors". Drug Discovery Today. 21 (2): 315–324. doi:10.1016/j.drudis.2015.11.001. ISSN 1359-6446. PMID 26589832.

Kynurenine 3-monooxygenase (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

harvard.edu (Global: 18th place; English: 17th place)